Many of the neuroprotective, neurodegenerative, psychiatric, and addiction-related applications discussed remain investigational, and no GLP-1 receptor agonist is currently approved by regulatory authorities for the treatment or prevention of Alzheimers disease, Parkinsons disease, depression, substance use disorders, or other neurological indications unless specifically stated otherwise
For patients eager to start or continue treatment without gaps, this matters
Cancellations, Refunds, and Commitment Terms Two-month minimum medication purchase required Early cancellations do not stop scheduled payments Subscription fees are nonrefundable Credit may be issued if the medication is not shipped Refunds or credits are available to those who lose less than 10% of their starting weight Trust and Transparency Shed is up-front about its pricing, with no hidden fees or aggressive upselling, and works with fully credentialed, experienced providers
Applications: Optimized for use in bench-top research, cell culture studies, and experimental pharmacological profiling
Then GLP-1 medications like semaglutide and its brand counterparts exploded in popularity